Please assess the completion status of the following clinical trial:

Trial Title: Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Female, age 50-75~2. Postmenopausal~3. Major Depressive Disorder~4. Currently treated with SSRI or SNRI at adequate dose~Exclusion Criteria:~1. Serious suicide or homicide risk~2. Unstable medical illness~3. Substance use disorder~4. Psychosis~5. Use of hormones (estrogens, androgens or related hormones)~6. History of hormone responsive cancer~7. Receiving strong CYP3A4 inducers or inhibitors or who intend to consume grapefruit products regularly during the study~8. Alanine aminotransferase (ALT) or creatinine \> 3x upper limit of normal

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Ganaxolone (Type: EXPERIMENTAL): Participants received ganaxolone

Based on this trial design, predict the completion outcome and termination type (if applicable).